Empowering Netflix Series ‘Skin Decision: Before and After’ Scores 2021 Emmy Nomination for Its Debut Season

On the heels of its debut season, Netflix’s original medical/lifestyle reality show Skin Decision: Before and After has received a 2021 Emmy nomination for “Outstanding Lifestyle Series.” The series takes a unique approach to its genre, as it seeks to bring healing, confidence, and self-empowerment to people who have endured traumatic and life-altering experiences.

Featuring board-certified plastic surgeon Dr. Sheila Nazarian, Skin Decision goes beyond superficial appearances and highlights the beauty within each patient while sharing intimate and emotional stories of real-life people who have suffered everything from confidence-crushing relationships to near-fatal car crashes.

When this project came up, I was so excited to get involved. I really wanted to make a new kind of plastic surgery show. Not a circus. Not demeaning to patients,” Nazarian says. “With this show, we really elevated plastic surgery and aesthetic treatments and showed the very real reasons why people get work done. Also, we showed that looking better can make people feel better and do better.”

Though future plans for the show have yet to be disclosed, Dr. Nazarian has many other accomplishments in sight. In addition to running her private practice in Beverly Hills, she will be expanding into Lake Tahoe soon with Spa26& Nazarian Plastic Surgery. Her non-profit, Nazarian Institute and ThinkBIG!, is growing to include surgical education and techniques for other board-certified plastic surgeons. Her ecommerce site The Skin Spot is ready for its re-launch with the new Skin Quiz, curated medical-grade skincare product offerings, Loyalty Points, and a sampling program. She also intends to continue her activism work to end racism against Jews all around the world.

The full series of Skin Decision: Before and After is available on Netflix. The 2021 Emmy Awards will be broadcast on Sept. 19, 2021, on CBS.

 

 

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.